Eupraxia Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:EPRXF)

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eupraxia Pharmaceuticals in the last year. There are currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" EPRXF shares.
View EPRXF analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 1-year price targets for Eupraxia Pharmaceuticals' shares. Their EPRXF share price targets range from C$18.00 to C$18.00. On average, they expect the company's share price to reach C$18.00 in the next year. This suggests a possible upside of 326.0% from the stock's current price.
View analysts price targets for EPRXF or view top-rated stocks among Wall Street analysts.

Eupraxia Pharmaceuticals' stock was trading at C$2.69 at the beginning of 2023. Since then, EPRXF shares have increased by 57.1% and is now trading at C$4.23.
View the best growth stocks for 2023 here.

Eupraxia Pharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,800 shares, an increase of 13.7% from the October 15th total of 5,100 shares. Based on an average daily volume of 1,400 shares, the short-interest ratio is presently 4.1 days.
View Eupraxia Pharmaceuticals' Short Interest.

Shares of EPRXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.